NFL Biosciences SAS (ALNFL) — Financial Flexibility Index
NFL Biosciences SAS (ALNFL) has a Financial Flexibility Index of 0.02x as of June 2023. Free cash flow of €57.51K (operating CF €57.51K minus capex €0.00) represents 0% of total liabilities (€3.67 Million). Check how aggressively does NFL Biosciences SAS reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NFL Biosciences SAS Financial Flexibility Index (2020–2022)
Historical Financial Flexibility Index trend for NFL Biosciences SAS across 3 annual periods. For the full cash flow conversion analysis, see NFL Biosciences SAS (ALNFL) cash conversion ratio.
Annual Financial Flexibility Index for NFL Biosciences SAS (2020–2022)
Year-by-year free cash flow to debt coverage for NFL Biosciences SAS. Explore NFL Biosciences SAS debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.07x | €104.89K | €104.89K | €1.55 Million | ▼ -69.1% |
| 2021 | 0.22x | €87.00K | €87.00K | €397.73K | ▲ +11.2% |
| 2020 | 0.20x | €83.91K | €83.91K | €426.61K | — |